28 results on '"Kumada, Hiromitsu"'
Search Results
2. Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients
3. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: Histological improvement or entecavir resistance?
4. Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis
5. Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: Randomized controlled trial in Japanese patients
6. Peginterferon α-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients
7. Peginterferon alfa-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in treatment-naive Japanese chronic hepatitis C patients: efficacy and safety of a randomised, double-blind, multicentre, phase III trial: 74
8. Origin of neovascular structure in an early stage of hepatocellular carcinoma: Study of alpha-smooth muscle actin immunohistochemistry in serial thin sections of surgically resected cancer
9. Virological differences between patients infected with subtypes Ba and Bj of hepatitis B virus genotype B
10. Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B
11. Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: Long-term follow up of a pilot study
12. Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome
13. Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: A pilot study
14. Safety and efficacy of elbasvir/grazoprevir in Asian participants with hepatitis C virus genotypes 1 and 4 infection
15. Vaniprevir plus peginterferon alfa‐2b and ribavirin in treatment‐experienced Japanese patients with hepatitis C virus genotype 1 (GT1b) infection: Phase 3 studies
16. Randomized comparison of daclatasvir + asunaprevir versus telaprevir + peginterferon/ribavirin in Japanese hepatitis C virus patients
17. Peginterferon ?-2a (40�KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients
18. Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B
19. Relationship of angiographic finding with neovascular structure detected by immunohistochemical staining of alpha-smooth muscle actin in small hepatocellular carcinoma
20. Relationship of angiographic finding with neovascular structure detected by immunohistochemical staining of α-smooth muscle actin in small hepatocellular carcinoma
21. Biochemical and histological features of hepatitis G virus infection
22. Predictive factors in eradicating hepatitis C virus using a relatively small dose of interferon
23. CASE REPORT: Clinical and virological analyses of a patient positive for hepatitis C virus-RNA by branched DNA assay but negative for anti-hepatitis C virus antibodies
24. Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: A multi-institution analysis
25. Antiviral effect of lymphoblastoid interferon‐alpha on hepatitis C virus in patients with chronic hepatitis type C
26. Factors useful in predicting the response to interferon therapy in chronic hepatitis C
27. Genotypic subtyping of hepatitis C virus
28. Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.